Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmaceutics

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/MP050012XPMID 15934781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.

  2005cited by this paper
• Regulation of alpha1(I) collagen messenger RNA decay by interactions with alphaCP at the 3'-untranslated region.

  2004cited by this paper
• Toxicology of antisense therapeutics.

  2004cited by this paper
• Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys.

  2004cited by this paper
• RNA interference targeting Fas protects mice from fulminant hepatitis

  2003cited by this paper
• Caspase 8 small interfering RNA prevents acute liver failure in mice

  2003cited by this paper
• Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

  2002cited by this paper
• Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.

  2002cited by this paper
• Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy.

  2002cited by this paper
• Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides*

  2001cited by this paper
• Delivery of cholesteryl-conjugated phosphorothioate oligodeoxynucleotides to Kupffer cells by lactosylated low-density lipoprotein.

  2001cited by this paper
• Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice.

  2000cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.

  1999cited by this paper
• Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding*

  1999cited by this paper
• In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration.

  1998cited by this paper
• Co-administration of polyanions with a phosphorothioate oligodeoxynucleotide (CGP 69846A): a role for the scavenger receptor in its in vivo disposition.

  1998cited by this paper
• Triple helix formation with the promoter of human alpha1(I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide.

  1998cited by this paper
• Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine).

  1997cited by this paper
• Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.

  1997cited by this paper
• In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.

  1997cited by this paper
• Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude Mice

  1997cited by this paper
• Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration.

  1997cited by this paper
• Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.

  1997cited by this paper
• Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice.

  1996cited by this paper
• Uptake Characteristics of Oligonucleotides in the Isolated Rat Liver Perfusion System

  1996cited by this paper
• The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.

  1995cited by this paper
• Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.

  1995cited by this paper
• Pharmacokinetics of Antisense Oligonucleotides

  1995cited by this paper
• Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

  1994cited by this paper
• Fibrogenesis and type I collagen gene regulation.

  1994cited by this paper
• Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.

  1994cited by this paper
• Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice.

  1992cited by this paper
• In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides.

  1992cited by this paper
• Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

  1991cited by this paper
• Isolation, purification, and characterization of liver cell types.

  1990cited by this paper
• Isolation and cultivation of rat liver stellate cells.

  1990cited by this paper
• Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells.

  1988cited by this paper
• A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat.

  1987cited by this paper
• A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat.

  1985cited by this paper
• A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.

  1981cited by this paper

• Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts

  2022cites this paper
• MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3.

  2021cites this paper
• CRISPR/Cas9 therapeutics for liver diseases

  2018cites this paper
• Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells.

  2018cites this paper
• Gene Therapy for Liver Disease

  2017cites this paper
• Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells.

  2017cites this paper
• Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX

  2017cites this paper
• Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery.

  2017cites this paper
• Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model

  2017cites this paper
• Discovery of Peptide and Aptamer Ligands for Targeted Drug Delivery to Hepatic Stellate Cells

  2016cites this paper
• Gene editing technology as an approach to the treatment of liver diseases

  2016cites this paper
• Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice

  2016cites this paper
• Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.

  2016cites this paper
• New gene therapy strategies for hepatic fibrosis.

  2015cites this paper
• Liver‐targeted gene therapy: Approaches and challenges

  2015cites this paper
• Discovery of Peptide ligands for hepatic stellate cells using phage display.

  2015cites this paper
• Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK

  2014cites this paper
• Optimization of the Formulation and Design of Oligonucleotide-based Pharmaceuticals for the Purpose of Gene Therapy

  2012cites this paper
• Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury

  2012cites this paper
• Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA

  2011cites this paper
• Targeted TFO delivery to hepatic stellate cells.

  2011cites this paper
• Development and evaluation of nano-scale systems for targeted delivery to treat liver fibrosis

  2011influential citation
• PCBP 2 siRNA Reverses the Alcohol-induced Pro-fibrogenic Effects in Hepatic Stellate Cells

  2011cites this paper
• PCBP2 siRNA Reverses the Alcohol-induced Pro-fibrogenic Effects in Hepatic Stellate Cells

  2011cites this paper
• Electrogenerated chemiluminescence detection of adenosine based on triplex DNA biosensor.

  2011cites this paper
• Triplex forming oligonucleotides against type α1(I) collagen attenuates liver fibrosis induced by bile duct ligation.

  2010influential citation
• Potentialités anti-inflammatoires de l'inhibition génomique et transcriptionnelle du TNF-[alpha] par une approche de type oligonucléotidique

  2010cites this paper
• Therapeutic gene delivery to human pancreatic islets for treatment of diabetes and the effect of TFO on liver fibrosis induced by bile duct ligation

  2010cites this paper
• Reversing Age-Related DNA Damage Through Engineered DNA Repair

  2010cites this paper
• Prevention of Liver Fibrosis by Triple Helix-Forming Oligodeoxyribonucleotides Targeted to the Promoter Region of Type I Collagen Gene

  2010influential citation
• Radiolabelled oligonucleotides for imaging of gene expression with PET.

  2009cites this paper
• Non-Hybridization Saturable Mechanisms Play a Role in the Uptake of 68Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides in Rats

  2009influential citation
• HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.

  2009cites this paper
• Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.

  2008cites this paper
• Phosphorothioate oligonucleotide inhibits tissue factor expression in endothelial cells induced by blood flow shear stress in rats

  2008cites this paper
• Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation

  2008cites this paper
• Sequence-specific triple helix formation with genomic DNA.

  2007cites this paper
• Gene modulation for treating liver fibrosis.

  2007influential citation
• Radiolabelled Oligonucleotides for Evaluation of in vivo Hybridisation Utilising PET Methodology

  2007cites this paper
• Bioconjugation of Oligonucleotides for Treating Liver Fibrosis

  2007cites this paper
• Enhanced Hepatic Uptake and Bioactivity of Type α1(I) Collagen Gene Promoter-Specific Triplex-Forming Oligonucleotides after Conjugation with Cholesterol

  2006cites this paper
• c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.

  2006cites this paper
• Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats.

  2006cites this paper
• Step into the groove: engineered transcription factors as modulators of gene expression.

  2006cites this paper